Effective treatment of low-risk acute GVHD with itacitinib monotherapy

Etra, A., Capellini, A., Alousi, A., Al Malki, M. M., Choe, H., DeFilipp, Z., Hogan, W. J., Kitko, C. L., Ayuk, F., Baez, J., Gandhi, I., Kasikis, S., Gleich, S., Hexner, E., Hoepting, M., Kapoor, U., Kowalyk, S., Kwon, D., Langston, A., … Levine, J. E. (2023). Effective treatment of low-risk acute GVHD with itacitinib monotherapy. Blood, 141(5), 481–489. https://doi.org/10.1182/blood.2022017442
Authors:
Aaron Etra
Alexandra Capellini
Amin Alousi
Monzr M. Al Malki
Hannah Choe
Zachariah DeFilipp
William J. Hogan
Carrie L. Kitko
Francis Ayuk
Janna Baez
Isha Gandhi
Stelios Kasikis
Sigrun Gleich
Elizabeth O. Hexner
Matthias Hoepting
Urvi Kapoor
Steven Kowalyk
Deukwoo Kwon
Amelia Langston
Marco Mielcarek
George Morales
Umut Özbek
Muna Qayed
Ran Reshef
Wolf Rösler
Nikolaos Spyrou
Rachel Young
Yi‐Bin Chen
James L.M. Ferrara
John E. Levine
Affiliated Authors:
Ran Reshef
Columbia Affiliation:
Subjects:
Graft vs Host Disease (MeSH)
Hematopoietic Stem Cell Transplantation (MeSH)
Hematopoietic Stem Cell Biology (OpenAlex Topic)
Natural Killer Cells in Immunity (OpenAlex Topic)
Epidemiology and Treatment of Childhood Leukemia (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood.2022017442
PMID:
36095841
DOI:
10.1182/blood.2022017442
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record

Record Created: